Call for Abstract

34th World Cardiology Conference, will be organized around the theme “Reconnoitering Challenges Concerning Prediction & Prevention of Heart Diseases”

World Cardiology 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in World Cardiology 2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Cardiovascular disease involves the improper functioning of heart or blood vessels. Cardiovascular disease includes coronary artery diseases such as angina and myocardial infarction (which is also known as a heart attack). Other cardiovascular diseases are stroke, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, atrial fibrillation, congenital heart disease, endocarditis, peripheral artery disease and venous thrombosis. It is expected that 90% of cardiovascular disease is avoidable. Prevention of atherosclerosis is by decreasing risk factors through: proper diet, exercise, avoidance of tobacco smoke and restrictive alcohol intake. Treating high blood pressure and diabetes is also beneficial. Treating people who have strep throat with antibiotics can reduce the risk of rheumatic heart disease. Cardiovascular diseases are the leading cause of death globally.

  • Track 1-1Congenital heart disease
  • Track 1-2 Cerebrovascular disease
  • Track 1-3Cerebrovascular disease
  • Track 1-4Rheumatic heart disease
  • Track 1-5Inflammatory heart disease
  • Track 1-6Peripheral arterial disease
  • Track 1-7Coronary artery disease
  • Track 1-8Cardiovascular diseases with obesity

A clinical cardiologist analyses and treats the disorder that affects the cardiovascular system, which includes the heart and the blood vessels. Cardiology congresses 2018 employees medications and other non-surgical procedures to cure and prevent the heart attacks, coronary artery diseases and other similar conditions. Cardiology 2018 includes Cardiovascular Medicine, Percutaneous Coronary Intervention and Application of Cardiac Progenitor Cells and many more to be discussed in international congress of cardiology. Many of the universities are working on Clinical Cardiology.

  • Track 2-1Cardiovascular medicines
  • Track 2-2Inflammatory Cardiomyopathy
  • Track 2-3Percutaneous coronary intervention (PCI)
  • Track 2-4Hypertension for the primary care clinician
  • Track 2-5Modern practices in cardiovascular therapy
  • Track 2-6Application of cardiac progenitor cells

Cardiac electrophysiology is the science deals with elucidating, diagnosing, and treating the electrical activities of the heart. The term is used to describe studies of such phenomena by invasive (intracardiac) catheter recording of spontaneous activity as well as of cardiac responses to programmed electrical stimulation (PES). These studies are performed to assess complex arrhythmias, elucidate symptoms, evaluate abnormal electrocardiograms, assess risk of developing arrhythmias in the future, and design treatment. These procedures mainly include therapeutic methods (typically radiofrequency ablation, or cryoablation) in addition to diagnostic and prognostic procedures. Other therapeutic modalities employed in this field include antiarrhythmic drug therapy and implantation of pacemakers and automatic implantable cardioverter-defibrillators (AICD).

  • Track 3-1Catheter ablation
  • Track 3-2Implantation of cardiac devices
  • Track 3-3Electrical conduction system of the heart
  • Track 3-4Electrocardiogram (ECG)
  • Track 3-5Radiofrequency ablation

Vascular heart diseases are any disease process involving one or more of the four valves of the heart (the aortic and mitral valves on the left and the pulmonary and tricuspid valves on the right). These conditions occur mostly as a result of aging. Most people are in their late 50s when diagnosed, and more than one in ten people over 75 have it.

  • Track 4-1Atherosclerosis and peripheral artery disease
  • Track 4-2Aneurysm
  • Track 4-3Peripheral venous disease and varicose veins

Interventional cardiology deals especially with the catheter based treatment of structural heart diseases. Andreas Gruentzig is considered the father of interventional cardiology after the enlargement of angioplasty by interventional radiologist Charles Dotter.

A large number of procedures can be accomplished on the heart by catheterization. This is most commonly method which is involves the insertion of a sheath into the femoral artery (but, in practice, any large peripheral artery or vein) and cannulating the heart under X-ray visualization. The radial artery also be used for cannulation; this approach deals with several advantages, including the accessibility of the artery in most patients, the easy control of bleeding even in anticoagulated patients, the enrichment of comfort because patients are capable of sitting up and walking immediately following the procedure, and the near absence of clinically significant sequelae in patients with a normal Allen test.

  • Track 5-1Cardiac catheterization
  • Track 5-2Angioplasty
  • Track 5-3Coronary Stents
  • Track 5-4Embolic protection
  • Track 5-5Percutaneous valve repair
  • Track 5-6Balloon valvuloplasty
  • Track 5-7Atherectomy
  • Track 6-1Transthoracic echocardiography
  • Track 6-2Transoesophageal echocardiography
  • Track 6-3Contrast echocardiography
  • Track 6-4 Lung ultrasound examination
  • Track 7-1Coronary artery bypass grafting
  • Track 7-2Trans myocardial Laser Revascularization
  • Track 7-3Heart valve repair or replacement
  • Track 7-4Heart Transplant
  • Track 7-5Aneurysm repair
  • Track 7-6Off-Pump heart surgery
  • Track 7-7 Cardiovascular diseases with breast cancer
  • Track 8-1Tetralogy of Fallot
  • Track 8-2 Pulmonary Atresia
  • Track 8-3Double Outlet Right Ventricle
  • Track 8-4 Transposition of Great Arteries
  • Track 9-1 Metabolic Syndrome and Ischemic Stroke
  • Track 9-2 Dyslipidemia and risk of Stroke
  • Track 9-3Diabetic, Metabolic Syndrome and Stroke prevention
  • Track 9-4Weight and diabetes
  • Track 10-1Cardiac resynchronization therapy
  • Track 10-2Defibrillation technology
  • Track 10-3Defibrillation technology
  • Track 10-4Cardiac pacemaker
  • Track 10-5 LV reverse remodeling
  • Track 10-6Defibrillator
  • Track 10-7Pacemaker
  • Track 10-8Intra-aortic balloon pump (IABP)
  • Track 11-1Case reports on heart Disease & failure
  • Track 11-2 Case reports on myocardial and pericardial Disease
  • Track 11-3Case reports on Arrhythmias
  • Track 11-4Case reports on Atherosclerosis
  • Track 11-5 Case reports on cardiac surgery
  • Track 11-6Case reports on heart regeneration
  • Track 12-1 Neuro cardiology
  • Track 12-2Pediatric cardiology
  • Track 12-3 Cardiovascular diseases in women
  • Track 13-1 Cardiac remodelling
  • Track 13-2 Cardiac stem cells
  • Track 13-3 Stem cell-derived engineered cardiac tissue
  • Track 13-4 Stem cells for myocardial regeneration
  • Track 13-5 Biomimetic heart valve replacement
  • Track 13-6 Trans-differentiation during heart regeneration
  • Track 13-7Congenital heart disease and regeneration
  • Track 13-8Heart repair, heart tissue regeneration and stem cells
  • Track 13-9Cardiac regenerative therapy
  • Track 13-10 Tissue graft cardiac cell replacement
  • Track 14-1Myocardial perfusion imaging
  • Track 14-2 Evaluation of cardiac function with radionuclide ventriculography
  • Track 14-3Assessment of myocardial Injury, infarction and infection
  • Track 14-4 Imaging of the nervous system of the heart
  • Track 14-5 Positron Emission Tomography (PET)
  • Track 15-1 Cardiovascular care of older people
  • Track 15-2Altered pharmacokinetics in aging
  • Track 15-3 Demographics of aging
  • Track 15-4 Geriatric medicine
  • Track 15-5Clinical geriatric cardiology
  • Track 16-1 Pulmonary hypertension
  • Track 16-2 Hypertension & heart disease
  • Track 16-3 Hypertension risk factors
  • Track 16-4 Pharmacological treatments for hypertension
  • Track 17-1 Dilated cardiomyopathy
  • Track 17-2Hypertrophic cardiomyopathy
  • Track 17-3Restrictive cardiomyopathy
  • Track 17-4 Arrhythmogenic right ventricular dysplasia
  • Track 17-5Cardiovascular nursing
  • Track 18-1Cardiac assessment nursing
  • Track 18-2Cardiac surgery nursing
  • Track 18-3 Telemetry care
  • Track 18-4Electrophysiology
  • Track 18-5 Stress test evaluations
  • Track 18-6 Pediatric cardiac nursing
  • Track 19-1 Heart attack symptoms for women
  • Track 19-2 Heart disease risk factors for women
  • Track 19-3 Prevention, diagnosis & treatment
  • Track 19-4Antiarrhythmic agents
  • Track 20-1Beta-adrenergic blocking agents
  • Track 20-2 Antihypertensive combinations
  • Track 20-3 Anticholinergic chronotropic agents
  • Track 20-4 Antiadrenergic agents
  • Track 21-1 Adults with congenital heart disease
  • Track 21-2Tetralogy of Fallot in Adults
  • Track 21-3 Pulmonary Artery Stenosis
  • Track 21-4Patent Foramen Ovale
  • Track 21-5 Patent Ductus Arteriosus
  • Track 21-6 Ebsteins Anomaly in Adults
  • Track 21-7 Coarctation of the Aorta
  • Track 21-8Atrial Septal Defect
  • Track 21-9 Cardiovascular connective tissue disorders
  • Track 21-10 Pulmonary Hypertension
  • Track 21-11 Ventricular Septal Defects - VSD
  • Track 22-1 Physiological changes during pregnancy and puerperium
  • Track 22-2Cardiovascular evaluation during pregnancy
  • Track 22-3Pregnancy and valvular heart disease
  • Track 22-4Pregnancy and congenital heart disease
  • Track 22-5Pregnancy and cardiomyopathy
  • Track 22-6Coronary artery disease in pregnancy
  • Track 23-1 Thoracic aortic aneurysm (stretched aorta in chest)
  • Track 23-2Congestive heart failure (ineffective heart muscle)
  • Track 23-3 Valvular stenosis (blocked or narrowed valves)
  • Track 23-4 Valvular insufficiency (leaking or regurgitation)
  • Track 23-5Left ventricular aneurysm (stretched heart muscle)
  • Track 23-6Left ventricular aneurysm (stretched heart muscle)
  • Track 23-7 Aorta transaction (a rupture through nearly all aorta layers from trauma, collisions or falls)
  • Track 23-8 Myocardial infarction (heart attack)
  • Track 23-9Congestive heart failure (ineffective heart muscle)
  • Track 23-10 Aortic dissection (bleeding in the aorta walls)
  • Track 23-11 Thoracoabdominal aortic aneurysm
  • Track 23-12Congestive heart failure (ineffective heart muscle)
  • Track 24-1 Hypertension diagnosis
  • Track 24-2Physical inactivity and cardiovascular disease
  • Track 24-3Tobacco and cardiovascular disease
  • Track 24-4 Diet and cardiovascular disease
  • Track 24-5Bad Fats
  • Track 24-6Blood lipids (fats) as a risk factor for cardiovascular disease
  • Track 24-7Obesity and cardiovascular disease
  • Track 24-8 Family history and cardiovascular disease
  • Track 24-9 Diabetes as a risk factor for cardiovascular disease